From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Latest News

VLX
premium content

Volex – interims, confidence in meeting outlook targets and a possible offer for TT Electronics?

Power and data transmission products manufacturer Volex (VLX) has announced results for its half-year ended 29th September 2024 and reiterated confidence in meeting outlook targets. So what of a share price of around 300p?
Clown
premium content

A failed fund manager writes about lies (is that his specialist subject?)

No not me silly.. I refer, of course , to disgraced Neil Woodford who writes about lies, damned lies and misleading data...
Bearcast
premium content

Tom Winnifrith Bearcast: Under what circumstances do I give up on Optibiotix and switch into Skins?

I start with the naivete of so many who blunder into running a restaurant. Then the farmers again. Then Optibiotix (OPTI), Skinbiotherapeutics (SBTX), Argo Blockchain (ARB), Evil Banksta, and Miriad Advertisting (MIRI)
TM1
premium content

EXPOSE: Technology Minerals: Breaking listing rules yet again, something it is not saying!!

Oh dear, Oh dear.. Turd polisher in chief Harry Chathli you really are a very naughty boy indeed. I think you need to be made to sit on the PR naughty step until Christmas and the chances of Santa thinking you have been a good boy and bringing you a bulging stocking, rather than a lump of coal, are reducing by the minute. The lesser transgression is the lack of accounts.
PRD
premium content

Predator Oil & Gas, the apparently missing NED and the jumping rats

As a perma bear I was delighted to receive an email from reader T highlighting yet more red flags at Predator oil & Gas (PRD) , a shortable £32 million stock, at 5.625p, where my short term target is 3p, my long term target 0p.
Bearcast
premium content

Tom Winnifrith Bonus Bearcast: Today's note from Cavendish on Skinbiotherapeutics is utterly pointless, here's my stab at forecasts

What is the point of Nomad and broker Cavendish? Giles Bellend lies to his client. Now it publishes a wholly pointless and amateurish research note on Sinbiotherapeutics (SBTX). I discuss that note and have a stab at doing the analyst's job for him.
BMN
premium content

BREAKING: Bushveld Minerals, sack the board GM called, too little too late

Yesterday Bushveld Minerals (BMN) put itself into the South African equivalent of Chapter 11. The day before its shares were suspended pending clarification. Stevie Wonder can see that shareholders will get nowt and that the company is well and truly fecked. But some folks are always optimistic. Step forward activist investor Kamran Sattar
Bearcast
premium content

Tom Winnifrith Bearcast: Jeremy Clarkson bloody well should pay full IHT

I start with the snow and lazy teachers hence the delayed bearcast, then to farmers and IHT where my views are maybe not as you might expect. Then it is onto Cirata (CRTA), UK Oil & Gas (UKOG) and to BSF Enterprise (BSFA)
AMRQ
premium content

Amaroq Minerals – Q3 results and key agreements for upcoming gold production, an upcoming catalysts Buy

Amaroq Minerals (AMRQ) has announced third quarter of 2024 results and “key agreements in preparation for gold production in Nalunaq” – on which it states it has “made significant headway”. This suggests further strong upside from a 79p share price, even after an initial 73p offer price tip.
CLX
premium content

Calnex Solutions – interims, how confident to be of “expects to close the year in line with current market expectations”?…

Shares in company describing itself as “a leading provider of test and measurement solutions for the global telecommunications and cloud computing markets”, Calnex Solutions (CLX) had recently recovered to above 64p but what of them currently back towards 60p following results for its half-year ended 30th September 2024?
CML
premium content

CML Microsystems – interims, is it really ‘progress showcasing the resilience and adaptability of the business model’?

Most recently writing on semiconductors developer CML Microsystems (CML), in August with the shares up to 305p I cautioned as its expectations included improvement in customer inventory levels to commence during the second half of the year. What of now the results and statement after its half-year ended 30th September 2024 and the shares currently down towards 230p?

ELEG
premium content

Electric Guitar – another bum note

Electric Guitar (ELEG) shares are down 31% today at time of writing valuing the company at £590,000. Back on 3 May 2024 when Electric completed its acquisition of 3radical it was admitted to AIM at 2.1 pence. The shares are now down to a bid price of 0.20 pence a more than 90% drop.
Gold

Video: Buying Gold Miners, Cheap Compared to Gold Itself

Libertarian analyst and investor Doug Casey insists that buying gold mining shares is as better bet than buying gold. I guess he has never met Kefi Gold & Copper (KEFI).
UKOG
premium content

UK Oil & Gas: more worthless confetti vicar?

Another day and it's another placing from Lyin’ Steve Sanderson at UK Oil & Gas (UKOG). As ever there is always a good reason. And as ever it is a hugely discounted bucket shop offering. Already the shares have slumped back to below 0.025p, the price at which £500,000 has been raised. There is a retail offer at the same price. Financial masochists know where to apply.
Bearcast
premium content

Tom Winnifrith bonus bearcast: ye or me or that idiot Magna Carta of little faith, Eco Buildings and Skinbiotherapeutics

as the snow lies not that thick on the ground I have bonus childcare duties as the lazy teachers take another day off. In this, therefore delayed, bonus bearcast I look at today's brilliant news from both Skinbiotherapeutics (SBTX) and Eco Buildings (ECOB) both of which now offer an incredibly attractive risk reward entry point.
FAB
premium content

Fusion Antibodies – interims argue “now well positioned”, but is it really?…

Antibody contract research company Fusion Antibodies (FAB) has announced results for its half-year ended 30th September 2024 with CEO Adrian Kinkaid emphasising that “the company is now well positioned, generating the financial evidence of a significant recovery and promising growth in the company's prospects”. What then of a current share price response more than 7.5% lower to 4.25p?
Clown
premium content

Is China fraud specialist Paul Shackleton doing a bit of a Rachel from Customer services on LinkedIn?

Oh dear, oh dear. It seems as if it is not only Rachel from Customer Services, aka our incompetent Chancellor whose LinkedIn profile neds a bit of doctoring. You will remember my numerous run ins with Mr Paul Shackleton who, while at Daniel Stewart (DAN) was the Nomad who helped support numerous China frauds, notably Naibu.
Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

Most Read in the Past Seven Days

That Was the Week that Was

Time left: 18:45:53